Glycine sales in the Russian Federation have been falling for the fifth year in a row. The newspaper reports this “Vedomosti” with reference to data from analytics company DSM Group.
The publication notes that in 2023, approximately 31 million packages of the drug were purchased from Russian pharmacies, which is 4.3% less than a year ago (32.4 million). The number had also decreased in previous years. In Russia, 37.6 million packs of glycine were sold in 2021, 40.6 million in 2020 and 46.6 million in 2019.
The publication emphasizes that doctors are beginning to prescribe the drug less frequently because its clinical effectiveness has never been proven. Depending on the diagnosis, patients were also prescribed other medications, such as antidepressants.
Before that, it was known that Corvalol would be sold in Russia at the end of 2023, according to DSM Group. collapsed To the lowest levels of 2018.
It is stated that sales of the drug have decreased in the last few years. Thus, 46 million packs of Corvalol were purchased from Russian pharmacies in 2021, and 50 million in 2020.
Previously reportedHe said the Ministry of Finance is considering imposing a special consumption tax on medicinal alcohol.
What are you thinking?
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.